Better together – Combining our elective care and diagnostic service expertise to strengthen clinical pathways
Xyla Elective Care and Xyla Diagnostics, both part of Acacium Group, have joined to become a single business under the Xyla Elective Care brand. By combining our service expertise we’ll strengthen clinical pathways and provide customers with a single point of contact to help manage waitlist challenges.
Both brands share common characteristics, including being clinically led and focussed on innovative service design. In 2021 we provided clinical services to more than 90,000 patients for 57 clients, and I am hugely excited about the reach and impact Xyla Elective Care can have in 2022 and beyond.
It is business as usual for our current clients with no impact on operational delivery.
If you would like more information on how we can support you please contact us on 020 7713 2756 or email us on firstname.lastname@example.org
Managing Director, Xyla Elective Care